Quantcast

Cannabis-based drugs possible next year in U.K.

Cannabis-based drugs could be prescribed in the United Kingdom as early as 2003 following word from a British pharmaceutical company that four Phase III clinical trials showed the drugs successfully treated symptoms associated with multiple sclerosis and neuropathic pain. In the trials, the pot-based medicine achieved statistically significant reductions in neuropathic (nerve-damage) pain, as well as statistically significant improvements in other symptoms of MS, most notably spasticity and sleep disturbance.